A Study of Pembrolizumab in Patients With Advanced Gynaecological Clear Cell Cancer

Clinical trial NCT03425565 · UNKNOWN

Trial details

NCT number: NCT03425565
Sponsor: University College, London
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Clear Cell Tumor Gynecologic Cancer Advanced Cancer

Start date: 2019-02-18
Primary completion: 2024-09-01
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.